Dr. Bussolati is author of >200 original articles in peer-reviewed journals. Pubmed link: http://www.ncbi.nlm.nih.gov/pubmed/?term=Bussolati+B
h-index: 54 (Scopus)
During my first years of research, I acquired a strong background in renal pathophysiology, and angiogenesis and studied the mechanisms of renal damage and progression. In addition, I have extensive experience in studies of stem cell biology and regenerative medicine that include the characterization of various stem cell types and their potential use for tissue regeneration. I’m focusing on the role of stem cell-derived extracellular vesicles (EVs) in regenerative medicine as therapeutic tools. I'm also interested in the molecular mechanisms exploited by stem cell-derived EVsto to induce cell reprogramming and modulate angiogenesis and renal repair.
In my laboratory, we have acquired a high expertise in the analysis of EV marker expression at a single-EV level, and have the availability of a dedicated instrument platform including Super-resolution microscopy and ExoView chip-based analysis. I am deeply involved in the EV community, as founder and President of the Italian Society for Extracellular Vesicles (EVIta), speaker at the EV Gordon Conferences (Sunday River Aug. 2018, Sunday River July. 2022), Treasurer of the International Society of Extracellular Vesicles (ISEV), member of the ISEV Task Force on Regulatory Affairs and Clinical Use of Extracellular vesicle-based Therapeutics and of the ISEV Task Force on Urinary Extracellular Vesicles.
